Characterization of hemolysin of Moraxella bovis using a hemolysis- neutralizing monoclonal antibody

Infection and Immunity

Volumn 68, Issue 6, 2000, Pages 3469-3474

  Billson, F Mark ^a,d   Harbour, Colin ^a   Michalski, Wojtek P ^b   Tennent, Jan M ^b   Egerton, John R ^a   Hodgson, Jennifer L ^a,c  

^a UNIVERSITY OF SYDNEY   (Australia)

^b CSIRO   (Australia)

^c University Veterinary Centre   (Australia)

^d UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EXOTOXIN; HEMOLYSIN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY G3 D7; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CATTLE; CORNEA EPITHELIUM; CYTOTOXICITY; ERYTHROCYTE; FEMALE; FIMBRIA; HEMOLYSIS; KERATOCONJUNCTIVITIS; MORAXELLA BOVIS; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL;

ANIMALS; BACTERIAL TOXINS; CATTLE; EPITHELIUM, CORNEAL; EXOTOXINS; HEMOLYSIN PROTEINS; HEMOLYSIS; MORAXELLA (MORAXELLA) BOVIS;

EID: 0034110501     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.68.6.3469-3474.2000     Document Type: Article

References (39)

1. Bauer, M. E., and R. A. Welch. 1996. Association of RTX toxins with erythrocytes. Infect. Immun. 64:4665-4672.
2. Beard, M. K. M. 1991. Ph.D. thesis. University of Sydney, Sydney, Australia.
3. Beard, M. K., and L. J. Moore. 1994. Reproduction of bovine keratoconjunctivitis with a purified hemolytic and cytotoxic fraction of Moraxella bovis. Vet. Microbiol. 42:15-33.
4. Bhakdi, S., and J. Tranum-Jensen. 1988. Damage to cell membranes by pore-forming bacterial cytolysins. Prog. Allergy 40:1-43.
5. Bhakdi, S., N. Mackman, J. M. Nicaud, and I. B. Holland. 1986. Escherichia coli hemolysin may damage target cell membranes by generating transmembrane pores. Infect. Immun. 52:63-69.
6. Billson, F. M., J. L. Hodgson, J. R. Egerton, A. W. Lepper, W. P. Michalski, C. L. Schwartzkoff, P. R. Lehrbach, and J. M. Tennent. 1994. A hemolytic cell-free preparation of Moraxella bovis confers protection against infectious bovine keratoconjunctivitis. FEMS Microbiol. Lett. 124:69-73.
7. Boehm, D. F., R. A. Welch, and I. S. Snyder. 1990. Calcium is required for binding of Escherichia coli hemolysin to erythrocyte membranes. Infect. Immun. 58:1951-1958.
8. Boehm, D. F., R. A. Welch, and I. S. Snyder. 1990. Domains of Escherichia coli hemolysin (HlyA) involved in binding of calcium and erythrocyte membranes. Infect. Immun. 58:1959-1964.
9. Bohach, G. A., and I. S. Snyder. 1986. Composition of affinity-purified α-hemolysin at Escherichia coli. Infect. Immun. 53:435-137.
10. Brown, M. H., A. H. Brightman, B. W. Fenwick, and M. A. Rider. 1998. Infectious bovine keratoconjunctivitis: a review. J. Am. Vet. Med. Assoc. 12:259-266.
11. Clinkenbeard, K. D., and A. E. Thiessen. 1991. Mechanism of action of M. bovis hemolysin. Infect. Immun. 59:1148-1152.
12. Clinkenbeard, K. D., D. A. Mosier, and A. W. Confer. 1989. Transmembrane pore size and role of cell swelling in cytotoxicity caused by Pasteurella hemolytica leukotoxin. Infect. Immun. 57:420-425.
13. Cruz, W. T., R. Young, Y. F. Chang, and D. K. Struck. 1990. Deletion analysis resolves cell-binding and lytic domains of the Pasteurella leukotoxin. Mol. Microbiol. 4:1933-1939.
14. Devenish, J., and S. Rosendal. 1991. Immunological characterization of breakdown peptides of the 104 kilodalton hemolysin at Actinobacillus pleuropneumoniae serotype 1. Vet. Microbiol. 29:85-93.
15. Eberspacher, B., F. Hugo, and S. Bhakdi. 1989. Quantitative study of the binding and hemolytic efficiency of Escherichia coli hemolysin. Infect. Immun. 57:983-988.
16. Gray, J. T., P. J. Fedorka-Cray, and D. G. Rogers. 1995. Partial characterization of a Moraxella bovin cytolysin. Vet. Microbiol. 43:183-196.
17. Hoien-Dalen, P. S., R. F. Rosenbusch, and J. A. Roth. 1990. Comparative characterization of the leukocidic and hemolytic activity of Moraxella bovis. Am. J. Vet. Res. 51:191-196.
18. Ji, G. E., and P. O'Hanley. 1990. Epitopes of Escherichia coli hemolysin: identification of monoclonal antibodies that prevent hemolysis. Infect. Immun. 58:3029-3035.
19. 51Cr-labeled bovine neutrophils. Am. J. Vet. Res. 50:18-21.
20. Kagonyera, G. M., L. W. George, and R. Munn. 1989. Cytopathic effects of Moraxella bovis on cultured bovine neutrophils and corneal cells. Am. J. Vet. Res. 50:10-17.
21. Kuhnert, P., B. Heyberger-Meyer, A. P. Burnens, J. Nicolet, and J. Frey. 1997. Detection of RTX toxin genes in gram-negative bacteria with a set of specific probes. Infect. Immun. 63:2258-2265.
22. Lepper, A. W. 1988. Vaccination against infectious bovine keratoconjunctivitis: protective efficacy and antibody response induced by pili of homologous and heterologous strains of Moraxella bovis. Aust. Vet. J. 65:310-316.
23. Lepper, A. W. D., J. L. Atwell, P. R. Lehrbach, C. L. Schwartzkoff, J. R. Egerton, and J. M. Tennent. 1995. The protective efficacy of cloned Moraxella bovis pili in monovalent and multivalent vaccine formulations against experimentally induced infectious bovine keratoconjunctivitis. Vet. Microbiol. 45:129-138.
24. Ludwig, A., and W. Goebel. 1999. The family of the multigenic encoded RTX toxins, p. 330-348. In J. E. Alouf and H. Freer (ed.), The comprehensive sourcebook of bacterial protein toxins. II: membrane damaging toxins, 2nd ed. Academic Press, London, England.
25. Michalski, W. P., and J. M. Tennent. 1995. Glycosylation status of type IV pilin proteins from Gram-negative bacteria. Prot. Sci. 4(Suppl. 1):128.
26. Michalski, W. P., J. K. Crooks, S. J. Prowse, J. M. Tennent, and A. W. Lepper. 1993. Purification of proteases by immobilized-bacitracin A chromatography. Protein purification and biochemical engineering, Keystone Symposia on Molecular and Cellular Biology, Santa Fe, New Mexico. J. Cell. Biochem. 53(Suppl. 17A):50.
27. Moore, L. J., and A. W. Lepper. 1991. A unified serotyping scheme for Moraxella bovis. Vet. Microbiol. 29:75-83.
28. Moore, L. J., and J. M. Rutter. 1987. Antigenic analysis of fimbrial proteins from Moraxella bovis. J. Clin. Microbiol. 25:2063-2070.
29. New, J. C. 1991. Costs of veterinary services and vaccines/drugs used for prevention and treatment of diseases in 60 Tennessee cow-calf operations (1987-1988). J. Am. Vet. Med. Assoc. 198:1334-1340.
30. O'Hanley, P., R. Marcus, K. H. Back, K. Denich, and G. E. Ji. 1993. Genetic conservation of hlyA determinants and serological conservation of HlyA: basis for developing a broadly cross-reactive subunit Escherichia coli alpha-hemolysin vaccine. Infect. Immun. 61:1091-1097.
31. Oropeza-Wekerle, R. L., E. Muller, P. Kern, R. Meyermann, and W. Goebel. 1989. Synthesis, inactivation, and localization of extracellular and intracellular Escherichia coli hemolysins. J. Bacteriol. 171:2783-2788.
32. Parge, H. E., K. T. Forest, M. J. Hickey, D. A. Christensen, E. D. Getzoff, and J. A. Tainer. 1995. Structure of the fibre-forming protein pilin a 2.6A resolution. Nature 378:32-38.
33. Raadsma, H. W., T. J. O'Meara, J. R. Egerton, P. R. Lehrbach, and C. L. Schwartzkoff. 1994. Protective antibody titres and antigenic competition in multivalent Dichelobacter nodosus fimbrial vacines using characterized rDNA antigens. Vet. Immunol. Immunopathol. 40:253-274.
34. Rogers, D. G., N. F. Cheville, and G. W. Pugh. 1987. Pathogenesis of corneal lesions caused by Moraxella bovis in gnotobiotic calves. Vet. Pathol. 24:287-295.
35. Slatter, D. H., M. E. Edwards, C. D. Hawkins, and G. E. Wilcox. 1982. A national survey of the clinical features, treatment and importance of infectious bovine keratoconjunctivitis. Aust. Vet. J. 59:69-72.
36. Taichman, N. S., M. Iwase, E. T. Lally, S. J. Shattil, M. E. Cunningham, and H. M. Korchak. 1991. Early changes in cytosolic calcium and membrane potential induced by Actinobacillus actinomycetemcomitans leukotoxin in susceptible and resistant target cells. J. Immunol. 147:3587-3594.
37. Thrift, F. A., and J. R. Overfield. 1974. Impact of pinkeye (infectious bovine keratoconjunctivitis) on weaning and postweaning performance of hereford calves. J. Anim. Sci. 38:1179-1184.
38. Weiss, A. A., E. L. Hewlett, G. A. Meyers, and S. Falkow. 1984. Pertussis toxin and extracytoplasmic adenylate cyclase as virulence factors of Bordetella pertussis. J. Infect. Dis. 150:219-222.
39. Welch, R. A., C. Forestier, A. Lobo, S. Pellett, W. Thomas, Jr., and G. Rowe. 1992. The synthesis and function of the Escherichia coli hemolysin and related RTX exotoxins. FEMS Microbiol. Immunol. 5:29-36.